Axogen, Inc. Common Stock
Veridion Score
Composite trend over time
Why is AXGN moving today?
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for AXGN.
AXGN insider activity
Axogen, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for AXGN.
AXGN contract awards, year to date.
Public federal awards linked to this ticker.
AXGN lobbying filings, year to date.
Registered lobbying filings matched to Axogen, Inc. Common Stock.